calanolide a has been researched along with Acquired Immune Deficiency Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buckheit, RW; Flavin, MT; Khilevich, A; Lin, L; Rizzo, JD; Stup, TL; Xu, ZQ; Zembower, DE | 1 |
| Cos, P; Hermans, N; Maes, L; Pieters, L; Vanden Berghe, D; Vlietinck, A | 1 |
| Kostova, I | 1 |
2 review(s) available for calanolide a and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Plant substances as anti-HIV agents selected according to their putative mechanism of action.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; HIV Integrase Inhibitors; HIV Reverse Transcriptase; Molecular Structure; Plants, Medicinal; Virus Integration | 2004 |
Coumarins as inhibitors of HIV reverse transcriptase.
Topics: Acquired Immunodeficiency Syndrome; Animals; Anti-HIV Agents; Camphor; Coumarins; Drug Design; Drug Therapy, Combination; Humans; Lactones; Pyranocoumarins; Reverse Transcriptase Inhibitors; Structure-Activity Relationship | 2006 |
1 other study(ies) available for calanolide a and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Cell Line; Chromones; Coumarins; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Leukocytes; Macrophages; Monocytes; Pyranocoumarins; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; Structure-Activity Relationship; Virus Replication | 1998 |